RICHARD NIGON - 25 May 2022 Form 4 Insider Report for Celcuity Inc. (CELC)

Role
Director
Signature
/s/ Eric O. Madson as Attorney-in-Fact for Richard Nigon pursuant to Power of Attorney previously filed.
Issuer symbol
CELC
Transactions as of
25 May 2022
Net transactions value
+$4,482
Form type
4
Filing time
26 May 2022, 16:16:04 UTC
Previous filing
19 May 2022
Next filing
06 Sep 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELC Common Stock Purchase $4,482 +754 +0.84% $5.94 91,032 25 May 2022 Direct
holding CELC Common Stock 20,300 25 May 2022 By Grandchildren's Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CELC Warrants (right to buy) 5,061 25 May 2022 Common Stock 5,061 $9.50 Direct F1
holding CELC Warrants (right to buy) 4,672 25 May 2022 Common Stock 4,672 $7.56 Direct F1
holding CELC Warrants (right to buy) 3,245 25 May 2022 Common Stock 3,245 $7.56 Direct F1
holding CELC Warrants (right to buy) 8,461 25 May 2022 Common Stock 8,461 $8.42 Direct F1
holding CELC Warrants (right to buy) 1,429 25 May 2022 Common Stock 1,429 $8.42 Direct F1
holding CELC Stock Option (right to buy) 8,200 25 May 2022 Common Stock 8,200 $5.50 Direct F1
holding CELC Stock Option (right to buy) 3,201 25 May 2022 Common Stock 3,201 $5.50 Direct F1
holding CELC Stock Option (right to buy) 5,054 25 May 2022 Common Stock 5,054 $5.50 Direct F1
holding CELC Stock Option (right to buy) 25,308 25 May 2022 Common Stock 25,308 $5.10 Direct F1
holding CELC Stock Option (right to buy) 4,619 25 May 2022 Common Stock 4,619 $5.50 Direct F1
holding CELC Stock Option (right to buy) 24,449 25 May 2022 Common Stock 24,449 $5.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Currently exercisable.
F2 This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders.